Home > Back to Publisher > Report Information

The Global Biotechnology (Pharmaceuticals) Report

Plimsoll Publishing Ltd.
September 24, 2009
500 Pages - SKU: PLSL2443897

Abstract Table of Contents Related Reports

Countries covered: Global

The Global Biotechnology Report
Plimsoll Publishing Ltd.

Do you know....
The top 7 best trading partners in the industry?
Which company has the highest sales growth?
Which companies have the highest levels of debt?

This report is an in-depth financial evaluation of the Global Biotechnology Industry. Using the unique Plimsoll method of analysis, each of the top 500 Biotechnology Companies is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the two-page analysis provides detailed financial analysis for each organisation, including details of;

Sales growth
Trading stability
Profitability
Employee performance
Level of debt
Gearing ratio’s
Creditor Exposure
Performance ratio’s
Overall financial rating

Results are shown in graphical, numeric and narrative forms, and all individual analysis are measured in both the company’s own currency, and USD ($) for ease of use. These individual analyses highlight a company’s success just as easily as it can emphasise its vulnerability. Along with individual company information, this report also contains an assesment of the market, based on the companies analysed. This key information identifies;

Best trading partners (based on commercial and financial strength)
Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)
Profitability (Profit return on assets, pre-tax profit margins, industry average)
Fastest growing companies (performance matrix)

Companies can change at an alarming rate in a very short space of time, so it is vital that you keep up-to-date with any changes to your market, and how those changes can affect you. This report can provide you with an in-depth look at your industry, highlight new market opportunities and provide important information to help develop accurate strategic business plans. Whether you wish to benchmark your own company’s results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.

The delivery time is between 1-2 business days to allow the preparation of an updated version prior to dispatch.

This extensive report is broken into two parts:: • A complete financial assessment of the market, based on the companies analysed; • An individual analysis of each company (2 pages per company)
Specific areas included in the market assessment include;
Section 1 - Best Trading Partners (based on commercial and financial strength)
Section 2 - Sales & Market Performance: 2.1 - Sales Growth; 2.2 - Sales Return on Assets
Section 3 - Profitability: 3.1 - Pre-tax profit margin; 3.2 - Pre-tax profit return on total assets; 3.3 - Profitability
4. 0 - How to Use
5.0 - Individual Company Analysis: The individual company assessment gives a complete financial picture of each company listed, including a narrative summary of the analysis. One of our key indicators is the Plimsoll Chart which combines several performance figures to give an overall measurement of the financial strength of any company. The Plimsoll chart is complied through the analysis of several different areas, including;; Sales Growth, Trading Stability, Profitability, Working Capital, Gearing and Immediate Liquidity; As all measurements are standardised, in one report you can quickly compare like with like for every major company in your industry.
Each individual company analysis includes:: • A full four year financial assessment; • Debt indicator; • Latest sales/profitability rankings; • Employee Performance Analysis; • Comparisons against industry average; • Overall company financial rating; • Industry ranking matrix; • Company Summary
Other information in the report includes;: • Details of the Plimsoll Model; • Definition of Terms; • List of Shareholders; • Global Index by region; • Ranking Analysis by sales/profits; • Companies considered but not included; • Index of companies

More Global Biopharmaceuticals Reports

Global Biosimilars Market Forecast to 2015 by RNCOS
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, ...

Biosimilars: Current Situation & Future Prospects, Worldwide by JustPharmaReports.com
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with ...

World Biological Drugs Market 2012-2022 by Visiongain
Where is the market for biological drugs heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. Our new study ...

Global Biosimilars: A return to optimism? by Espicom Healthcare Intelligence
Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies - and some surprising names - are positioning themselves for ...

Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition by Kalorama Information
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent ...

See all reports like this >>

The Global Biotechnology (Pharmaceuticals) Report

Share this report

Other tasks

Research Assistance

Related Markets

Biopharmaceuticals Reports

Free Alert Me service